Immunovaccine Announces Positive Clinical Data from Its … – GlobeNewswire (press release)
|
Immunovaccine Announces Positive Clinical Data from Its …
GlobeNewswire (press release) HALIFAX, Nova Scotia, Dec. 05, 2017 (GLOBE NEWSWIRE) — Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced positive top-line clinical data from its ongoing Phase 1b trial evaluating the safety and … |
